African Oxygen Limited (Afrox) has reported a steady rise in revenue in its latest 2018 full-year financials.
African Oxygen Limited (Afrox) is currently upgrading its service facilities at hospitals across South Africa as part of its R150m investment strategy to deliver on the state healthcare tender award to supply hospitals and clinics across the nine provinces.
Laparoscopic surgery, commonly called keyhole surgery, is now widely established as a way to minimise patient trauma. The benefits include reduced postoperative pain and scarring, short hospital stays, better patient satisfaction and a much quicker recovery time.
HiQ gases from Afrox are ‘made for purpose’, and each has to comply with a specific set of specifications. This is particularly pertinent in the health sector, where the purity and accuracy of the gas mixtures used have a direct bearing on the health and treatment of patients.
Afrox has been playing a key role in the success rate of IVF fertility treatment in South Africa.